4 min read ·
Pre-seed vs seed: fund the next proof, not the stage label
Compare pre-seed and seed funding by product, customer evidence, round structure and milestones—and decide how to position your technical startup.

Pre-seed usually funds the work needed to validate a product and customer thesis. Seed usually funds the next step: turning early adoption into stronger evidence of a viable business. The difference is primarily what you have proved and what the capital will prove next—not a fixed raise amount, revenue threshold or financing document.
That is a working distinction, not a universal investor rule. CRV’s stage guide describes a shift from founder insight toward traction, while also noting that seed investors need a credible trajectory toward product-market fit, not necessarily proof that it has already been reached.
For technical founders, the useful question is: which uncertainty are we asking an investor to fund? For the broader progression through Series A and later, see what each funding stage needs to prove.
Pre-seed vs seed at a glance
Use this table to frame the round, rather than as an eligibility checklist.
| Dimension | Pre-seed framing | Seed framing |
|---|---|---|
| Main uncertainty | Can we build something a specific customer needs? | Can early adoption become a durable business? |
| Product evidence | Technical feasibility, prototype or early live product | Working product used in a real workflow |
| Customer evidence | Discovery, design partners and initial usage or payments | Repeated usage, retention, buying decisions and early expansion |
| Use of capital | Build, deploy and test the customer thesis | Improve reliability, deepen adoption and test a repeatable commercial motion |
| Investor case | Distinct insight, founder capability and a credible experiment | Customer evidence, execution and a credible path to product-market fit |
A pre-seed company can have revenue. A seed company can still have substantial product risk. Neither stage guarantees that demand is repeatable.
What counts as evidence for a technical product?
A demo proves that a product can work under the demonstrated conditions. It does not prove that someone will integrate it, depend on it or pay enough to support the business.
For fundraising, separate your evidence into three layers:
- Technical: Does the product meet the relevant performance, reliability or cost requirement on a representative workload?
- Workflow: Does the intended user actually adopt it, return to it and keep it deployed?
- Commercial: Who controls the budget, what triggers a purchase, and does the price cover delivery and support?
At pre-seed, a strong case might combine a differentiated technical result with customer access and a precise plan to test adoption. At seed, the case should show more of what happened after deployment—not just what customers said before it.
Consider a hypothetical data-infrastructure startup. It has a prototype that reduces processing time on one benchmark and two teams willing to test it. A useful pre-seed milestone would be production deployments on representative customer workloads, with measured performance and evidence that teams continue using the product.
Later, several customers use it regularly and some pay. The seed question becomes different: can the company reproduce that result across customers without extensive custom engineering? Funding might support reliability work, standard integrations and a test of whether buyers outside the founders’ network will purchase.
For applied AI, include inference, human review and support costs in the commercial evidence. A paid pilot is evidence of willingness to experiment; it is not automatically recurring revenue. See the stage-specific B2B SaaS and AI evaluation guide.
Round size and instruments do not settle the label
There is no useful dollar cutoff that cleanly separates every pre-seed from every seed round.
In Carta’s Q4 2025 data, 35% of pre-seed rounds were below $250,000, while 8% exceeded $5 million. Those observations show the spread within Carta’s dataset, not universal targets for founders. Carta’s March 2026 analysis also reports that about 87% of pre-seed deals above $4 million in 2025 used SAFEs.
So a large raise does not automatically make a company seed-stage, and a SAFE does not automatically make it pre-seed. CRV’s guide describes both SAFEs and priced rounds as options at seed.
Keep three decisions separate:
- Stage: How much of the company thesis is supported by evidence?
- Amount: What will it cost to reach the next meaningful milestone?
- Instrument: What legal and economic terms fit the financing?
YC’s SAFE documentation explains how its SAFE funds the company now in exchange for rights to future shares, including post-money ownership calculations. A priced equity round sets a share price and issues shares at the financing, as explained in YC’s seed-fundraising guide. Neither structure removes dilution. Model existing SAFEs, the proposed raise and future option-pool changes in your cap table.
Choose the round by writing the next proof
Before selecting a stage label, complete this sentence:
We have demonstrated X. The remaining uncertainty is Y. This round funds Z, and we will judge progress using these observable results.
Then budget the work: hires, infrastructure, deployment and support costs, plus time to evaluate results and pursue another financing if needed. Build a lower-raise version too. Identify which proof it can still deliver and what you would defer. YC’s seed-fundraising guide recommends tying the amount to a believable plan and preparing plans for different amounts raised; the capital-raising guide develops that milestone-first approach.
Use the label that best matches the evidence, then confirm each investor’s actual requirements: product maturity, customer traction, check size, ability to lead and preferred instrument. Do not inflate the stage to justify the amount you need.
Lunera describes its focus as the earliest moments of company building, when founder insight and product direction matter more than polished scale metrics; its homepage does not specify a formal pre-seed-versus-seed boundary. A useful pitch therefore starts with the customer, technical insight, what you have learned and what the next capital will establish—not the label alone.